tiprankstipranks
Trending News
More News >
Atossa Therapeutics (ATOS)
NASDAQ:ATOS
US Market

Atossa Therapeutics (ATOS) Income Statement

Compare
2,477 Followers

Atossa Therapeutics Income Statement

Last quarter (Q3 2025), Atossa Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Atossa Therapeutics's net income was $-8.69M. See Atossa Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 27.62M$ 31.38M$ 27.69M$ 20.52M$ 14.61M
Depreciation and Amortization
$ 17.00K$ 23.00K$ 8.00K$ 23.00K$ 47.00K
EBITDA
$ -27.60M$ -31.35M$ -27.68M$ -20.50M$ -14.56M
Operating Income
$ -27.62M$ -31.38M$ -27.69M$ -20.52M$ -14.61M
Other Income/Expenses
$ 2.12M$ 1.28M$ 731.00K$ -85.00K$ -3.22M
Pretax Income
$ -25.50M$ -30.09M$ -26.96M$ -20.61M$ -17.83M
Net Income
$ -25.50M$ -30.09M$ -26.96M$ -20.61M$ -17.83M
Per Share Metrics
Basic EPS
$ -0.20$ -0.24$ -0.21$ -0.18$ -1.97
Diluted EPS
$ -0.20$ -0.24$ -0.21$ -0.18$ -1.97
Weighted Average Shares Outstanding
125.86M 126.08M 126.62M 116.95M 11.31M
Weighted Average Shares Outstanding (Diluted)
125.86M 126.08M 126.62M 116.95M 11.31M
Currency in USD

Atossa Therapeutics Earnings and Revenue History